Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists
Keywords: LDL; low-density lipoprotein; HDL; high-density lipoprotein; cAMP; 3â²-5â²-cyclic adenosine monophosphate; SAR; structure-activity relationship; RLB; radioligand binding; GPCR; G-protein coupled receptor; BSA; bovine serum albumin; DCM; dichloromethane;